DPYD


Description

The dihydropyrimidine dehydrogenase (DPYD) gene plays a crucial role in the metabolism of fluoropyrimidine drugs, which are widely used in cancer chemotherapy. It encodes the DPYD enzyme, responsible for breaking down 5-fluorouracil (5-FU) and other fluoropyrimidines. Variations in the DPYD gene can lead to altered enzyme activity, affecting how effectively these drugs are metabolized. This can result in significant variations in drug efficacy and toxicity, making DPYD testing increasingly important in personalized medicine.

Associated Diseases

Did you know?

DPYD gene mutations are one of the most common causes of severe drug toxicity in cancer chemotherapy.


Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.